Javier Mariscal Avila

Title: Javier Mariscal Avila: Innovator in Prostate Cancer Detection

Introduction

Javier Mariscal Avila is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of medical technology, particularly in the early detection of clinically significant prostate cancer. His innovative approach combines advanced methods for isolating extracellular vesicles with the detection of specific proteins, paving the way for improved cancer diagnostics.

Latest Patents

Javier holds a patent for "Palmitoyl protein biomarkers in purified extracellular vesicles for early identification of clinically significant prostate cancer." This invention provides methods for isolating large extracellular vesicles (EVs) and detecting palmitoyl proteins within them. The methods also facilitate the detection of clinically significant prostate cancer based on the presence of these proteins in isolated large EVs from subjects in need. Furthermore, the invention includes administering cancer therapy to the subject, enhancing the potential for effective treatment.

Career Highlights

Throughout his career, Javier has worked with esteemed institutions such as Cedars-Sinai Medical Center and Vanderbilt University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer detection and treatment.

Collaborations

Javier has collaborated with notable professionals, including Dolores Di Vizio and Wei Yang. These partnerships have enriched his research and have been instrumental in advancing his innovative projects.

Conclusion

Javier Mariscal Avila's work in the field of prostate cancer detection exemplifies the impact of innovation in medical technology. His patented methods for isolating and detecting biomarkers represent a significant advancement in early cancer diagnosis and treatment.